Clinical Research Directory

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

Sponsor: Addpharma Inc.

Summary

Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.

Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of PA-111 Compared to PA-111A in Healthy Adult Volunteers Under Fed State Conditions

Key Details

Conditions

Interventions

Locations (1)